BridgeMD
Avoid With locoregional Analgesia Persistant Postoperative Pain After Surgery In Children
EU CTIS ID: 2023-503499-25-00
What this study is testing
To show the positive impact of locoregional Analgesia in the prevention of persistant postoperative Pain after orthopedic trauma surgery in children
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age ≥ 5 years and < 15 years and 3 month
- Indication for surgical treatment of a fracture by osteosynthesis
- Patient affiliated to the social security system
- Informed and signed consent of patient and one of the two holders of parental authority
- Conscious patient (Glasgow score =15)
- Patient can give a verbal assessment of their pain
You likely can't join if
- Refusal to participate by one of the two holders of parental authority or by the child
- atrioventricular conduction disorders
- Sensory neurological deficit of the operated limb on preoperative examination
- Ischemia of the operated limb on preoperative examination
- Polytrauma patient
- Known allergy to Mepivacaine
See the full eligibility criteria
- Age ≥ 5 years and < 15 years and 3 month
- Indication for surgical treatment of a fracture by osteosynthesis
- Patient affiliated to the social security system
- Informed and signed consent of patient and one of the two holders of parental authority
- Conscious patient (Glasgow score =15)
- Patient can give a verbal assessment of their pain
- Refusal to participate by one of the two holders of parental authority or by the child
- atrioventricular conduction disorders
- Sensory neurological deficit of the operated limb on preoperative examination
- Ischemia of the operated limb on preoperative examination
- Polytrauma patient
- Known allergy to Mepivacaine
- Patient included in a category 1 interventional clinical trial of analgesic therapy
- Patient on anticoagulant drugs
- Epilepsy not controlled by a treatment
- Porphyria
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.